Dr Nathan Kerr is a leading ophthalmologist specialising in glaucoma and cataract surgery. As an investigator for numerous clinical trials – including the PolyActiva first-in-human trial and TRITON study – Dr Kerr is at the forefront of innovative treatments for glaucoma. Dr Kerr has performed thousands of laser and MIGS procedures and is renowned for his expertise in this field. He performed the world’s first iTrack Advance procedure in 2022 and was the first Australian surgeon certified to implant the PreserFlo MicroShunt. He regularly trains fellow surgeons in these advanced techniques, both in Australia and internationally. Dr Kerr co-founded the iTrack Global Data Registry and the International Glaucoma Surgery Registry – contributing to the evidence base through multicentre research collaborations across the United States, Canada, Europe, and Australia.